These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7831005)

  • 1. Effect of the concentration and duration of application of mitomycin C in trabeculectomy.
    Neelakantan A; Rao BS; Vijaya L; Grandham SB; Krishnan N; Priya VS; Murugeshan R
    Ophthalmic Surg; 1994; 25(9):612-5. PubMed ID: 7831005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year follow-up of trabeculectomies performed with different concentrations of mitomycin-C.
    Mietz H; Krieglstein GK
    Ophthalmic Surg Lasers; 1998 Aug; 29(8):628-34. PubMed ID: 9715486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Episcleral versus combined episcleral and intrascleral application of mitomycin-C in trabeculectomy.
    Vass C; Menapace R; Strenn K; Rainer G
    Ophthalmic Surg Lasers; 1998 Sep; 29(9):714-21. PubMed ID: 9760606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trabeculectomy with mitomycin C in glaucoma associated with uveitis.
    Prata JA; Neves RA; Minckler DS; Mermoud A; Heuer DK
    Ophthalmic Surg; 1994; 25(9):616-20. PubMed ID: 7831006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of intraoperative 5-fluorouracil or lower dose mitomycin-C administration on initial trabeculectomy surgery.
    Smith MF; Doyle JW; Nguyen QH; Sherwood MB
    J Glaucoma; 1997 Apr; 6(2):104-10. PubMed ID: 9098818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trabeculectomy with mitomycin C in glaucoma associated with uveitis.
    Novak-Laus K; Mandić Z; Iveković R; Korsić J; Tedeschi-Reiner E; Masnec-Paskvalin S; Bojić L
    Coll Antropol; 2005; 29 Suppl 1():17-20. PubMed ID: 16193669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin-C in congenital glaucoma.
    Agarwal HC; Sood NN; Sihota R; Sanga L; Honavar SG
    Ophthalmic Surg Lasers; 1997 Dec; 28(12):979-85. PubMed ID: 9427984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the role of subconjunctival versus intrascleral application of mitomycin C in high-risk trabeculectomies.
    Agarwal HC; Saigal D; Sihota R
    Indian J Ophthalmol; 2001 Jun; 49(2):91-5. PubMed ID: 15884512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for mitomycin C use in glaucoma surgery.
    Maquet JA; Dios E; Aragón J; Bailez C; Ussa F; Laguna N
    Acta Ophthalmol Scand; 2005 Apr; 83(2):196-200. PubMed ID: 15799732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experiences and results of application of mitomycin C in trabeculectomy].
    Laube T; Ritters B; Selbach M; Hudde T
    Klin Monbl Augenheilkd; 2003 Sep; 220(9):618-24. PubMed ID: 14533060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of low-dose intraoperative mitomycin-C vs 5-fluorouracil in primary glaucoma surgery: a pilot study.
    Vijaya L; Mukhesh BN; Shantha B; Ramalingam S; Sathi Devi AV
    Ophthalmic Surg Lasers; 2000; 31(1):24-30. PubMed ID: 10976557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery.
    Palanca-Capistrano AM; Hall J; Cantor LB; Morgan L; Hoop J; WuDunn D
    Ophthalmology; 2009 Feb; 116(2):185-90. PubMed ID: 18930550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery.
    Mandal AK; Bagga H; Nutheti R; Gothwal VK; Nanda AK
    Eye (Lond); 2003 Jan; 17(1):53-62. PubMed ID: 12579171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of trabeculectomy with 0.3 mg/ml mitomycin C titrating exposure times based on risk factors for failure.
    Stone RT; Herndon LW; Allingham RR; Shields MB
    J Glaucoma; 1998 Feb; 7(1):39-44. PubMed ID: 9493114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial.
    Cillino S; Zeppa L; Di Pace F; Casuccio A; Morreale D; Bocchetta F; Lodato G
    Acta Ophthalmol; 2008 May; 86(3):314-21. PubMed ID: 17995980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical revision of failed filtration surgery with mitomycin C augmentation.
    Anand N; Arora S
    J Glaucoma; 2007 Aug; 16(5):456-61. PubMed ID: 17700288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of hypotony after primary trabeculectomy with antifibrotic agents in a black west African population.
    Singh K; Byrd S; Egbert PR; Budenz D
    J Glaucoma; 1998 Apr; 7(2):82-5. PubMed ID: 9559492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of early IOP in mitomycin-C augmented trabeculectomy.
    Alwitry A; Moodie J; Rotchford A; Abedin A; Patel V; King AJ
    J Glaucoma; 2007; 16(7):616-21. PubMed ID: 18091180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short term experience with "modern" trabeculectomy augmented with intraoperative antimetabolites.
    Detry-Morel M; Pourjavan S
    Bull Soc Belge Ophtalmol; 2005; (296):37-48. PubMed ID: 16050418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative effect of risk factors on short-term surgical success of mitomycin augmented trabeculectomy.
    Agarwal HC; Sharma TK; Sihota R; Gulati V
    J Postgrad Med; 2002; 48(2):92-6. PubMed ID: 12215687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.